Jeshmi Jeyabalan - Concepedia

Author

Jeshmi Jeyabalan

Also Known As

J Jeyabalan, J. Jeyabalan, Jeshmi Jeyabalan, Jeshmi Jeyabalan Srikaran, Jeshmi Jeyabalan-Srikaran, Jeyabalan, J, Jeyabalan-Srikaran, J.

Publications

853

Citations

H-Index

Concepts

All Affiliations

Churchill Hospital University of Oxford Oxford Centre for Diabetes, Endocrinology and Metabolism John Radcliffe Hospital Université Claude Bernard Lyon 1

About

Jeshmi Jeyabalan is an author at Churchill Hospital specializing in medicine, endocrinology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	236
2	Cell Biology	3	3	93
3	Health Sciences	2	2	151
4	Natural Sciences	1	1	35
5	Cellular Physiology	1	1	24

Jeshmi Jeyabalan

Publications

712

Citations

H-Index

Page 1

	Year	Citations
Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice Marie Pereira, Jeshmi Jeyabalan, Mark Hopkinson, Bone MechanobiologyGlucagon-like Peptide-1 ReceptorBone Morphogenic ProteinChronic AdministrationPhysiology	2015	127
Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia Brian Harding, Manuel C. Lemos, Adam J. Reed, Endocrine Related Cancer	2009	110
Asymptomatic Children with Multiple Endocrine Neoplasia Type 1 Mutations May Harbor Nonfunctioning Pancreatic Neuroendocrine Tumors Paul Newey, Jeshmi Jeyabalan, Gerard Walls, The Journal of Clinical Endocrinology & Metabolism	2009	97
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing Jeshmi Jeyabalan, Benoı̂t Viollet, Peter Smitham, Osteoporosis International	2013	96
Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers Manuel C. Lemos, Brian Harding, Adam J. Reed, Journal of Endocrinology	2009	47
Controlled-release systemic delivery - a new concept in cancer chemoprevention Ramesh C. Gupta, Sukhvinder S. Bansal, Farrukh Aqil, Carcinogenesis	2012	43
Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome Gerard Walls, Mark Stevenson, Kate E Lines, Oncogene	2017	38
<i>MEN1</i> Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas Gerard Walls, Manuel C. Lemos, Mahsa Javid, Cancer Research GeneticsImmunologyPathologyBrdurd IncorporationTumor Biology	2012	35
A Mouse with an N-Ethyl-N-Nitrosourea (ENU) Induced Trp589Arg Galnt3 Mutation Represents a Model for Hyperphosphataemic Familial Tumoural Calcinosis Christopher T. Esapa, Rosie Head, Jeshmi Jeyabalan, PLoS ONE GeneticsPathologyDisease Gene IdentificationCancer BiologyEpigenetics	2012	34
SEDLIN Forms Homodimers: Characterisation of SEDLIN Mutations and Their Interactions with Transcription Factors MBP1, PITX1 and SF1 Jeshmi Jeyabalan, M. Andrew Nesbit, Juris Galvanovskis, PLoS ONE	2010	27

Page 1